UBS issues 'Buy' recommendation for SolarEdge: "Will jump by 45%"

While a series of investment houses rushed to lower the target price for SolarEdge stock following the reports and the sharp drop, investment bank UBS chooses to go against the grain. The bank's analysts raised their recommendation for the Israeli stock from "Neutral" to "Buy" and set a target price of 42 dollars. Relative to the last closing price, around 29 dollars, this is an upside of about 45%.

What is behind the recommendation? Not the reports, but the administration. At the end of July, the Federal Communications Commission (FCC) imposed a ban on the import of new inverter models manufactured abroad, a step that is effectively aimed at China.

The inverter is the component that connects the solar panel to the power grid, and according to UBS's estimate, the ban may affect about 50% of the American inverter market and create a shortage in it that will benefit local manufacturers specifically.

Analyst John Windham explains the logic: a local market that is limited in supply means not only a larger market share for SolarEdge, but also pricing power, meaning the ability to raise prices. The bank emphasizes that the recommendation does not rely on future promises but on the existing and available product line already today, which makes the opportunity relatively immediate and not a distant vision.

An especially interesting point is the opening created for a product that has struggled until now: SolarEdge's industrial-scale inverter, the TerraMax model with a capacity of 330 kW, which has seen limited adoption in the market. If Chinese competitors are blocked, the product that struggled to take off may suddenly find demand for itself and open up a completely new arena for the company.

And here is the part that is important to understand: UBS's recommendation is a lone voice. Out of 27 analysts covering SolarEdge, 20 recommend "Hold." Furthermore, immediately after the reports at the beginning of August, several large investment houses actually cut the target price downwards. UBS is swimming against the consensus, and this increases both the chance and the risk in the bet.

To understand the context, one needs to return for a moment to the reports. SolarEdge presented a turnaround quarter, with revenues of 346.2 million dollars and a return to adjusted profit for the first time in almost three years.

But the weak forecast for the next quarter alarmed investors, and the stock plummeted about 30% in one day. In the last three months, the stock has lost about 58% of its value. Against the backdrop of this fall, UBS's target price looks especially ambitious, and it is betting that the market overreacted.

The bank's bet connects well with the position presented by SolarEdge CEO, Shuki Nir. In an interview and in the investor call, he positioned the regulatory change as a tailwind for the company: most of its production has already moved to the USA (Utah, Florida, and Texas), it meets the FCC requirements, and according to him, the ban is even "a step in the right direction."

Nir noted that in the commercial market (C&I), the company has already crossed a 50% share of rooftop installations, partly because major competitors do not meet local requirements and FEOC restrictions. In other words, the same regulation that burdens part of the market is exactly what may push customers to SolarEdge.

And what does this mean for you? SolarEdge is an extremely volatile stock, and UBS's recommendation illustrates how divided opinions are about it: on one side, a bank that sees an upside of 45%, and on the other, a majority that prefers to sit on the fence.

Anyone who holds a fund tracking the renewable energy sector in the USA or a pension portfolio exposed to technology likely holds this stock, and therefore it is worth knowing both sides. The opportunity, if it materializes, relies on regulation that is still taking shape, and that is exactly the source of the risk as well.